Vicente Arroyo
#97,810
Most Influential Person Now
Researcher
Vicente Arroyo's AcademicInfluence.com Rankings
Vicente Arroyocomputer-science Degrees
Computer Science
#3427
World Rank
#3596
Historical Rank
Computational Linguistics
#171
World Rank
#175
Historical Rank
Machine Learning
#402
World Rank
#407
Historical Rank
Artificial Intelligence
#596
World Rank
#607
Historical Rank
Download Badge
Computer Science
Vicente Arroyo's Degrees
- PhD Computer Science Stanford University
- Masters Computer Science University of California, Berkeley
Similar Degrees You Can Earn
Why Is Vicente Arroyo Influential?
(Suggest an Edit or Addition)Vicente Arroyo's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. (2013) (2069)
- Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis (1996) (1568)
- Peripheral arterial vasodilation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis (1988) (1523)
- Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. (1999) (1508)
- Compensated cirrhosis: Natural history and prognostic factors (1987) (1028)
- Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis (2007) (947)
- Bacterial infections in cirrhosis: Epidemiological changes with invasive procedures and norfloxacin prophylaxis (2002) (921)
- The management of ascites in cirrhosis: Report on the consensus conference of the international Ascites club (2003) (826)
- Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. (1993) (807)
- Acute-on chronic liver failure. (2012) (765)
- Management of cirrhosis and ascites. (2004) (754)
- Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013. (2014) (723)
- Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites. (2015) (672)
- Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure. (2014) (617)
- Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: Results of a double‐blind, placebo‐controlled trial (1990) (592)
- Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis. (1988) (570)
- Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis. (1996) (568)
- Renal impairment after spontaneous bacterial peritonitis in cirrhosis: Incidence, clinical course, predictive factors and prognosis (1994) (565)
- Obesity‐induced insulin resistance and hepatic steatosis are alleviated by ω‐3 fatty acids: a role for resolvins and protectins (2009) (559)
- Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: Results of a prospective, nonrandomized study (2002) (541)
- Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: A prospective study (2012) (523)
- The Long-term Results of a Randomized Clinical Trial of Laparoscopy-assisted Versus Open Surgery for Colon Cancer (2008) (522)
- Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis. (2007) (521)
- Circulatory function and hepatorenal syndrome in cirrhosis (2005) (512)
- Angiotensin II induces contraction and proliferation of human hepatic stellate cells. (2000) (464)
- Reticuloendothelial System Phagocytic Activity in Cirrhosis and Its Relation to Bacterial Infections and Prognosis (1984) (464)
- Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites. (1988) (459)
- Clinical Course of acute‐on‐chronic liver failure syndrome and effects on prognosis (2015) (455)
- Systemic inflammation in decompensated cirrhosis: Characterization and role in acute‐on‐chronic liver failure (2016) (455)
- Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute‐on‐chronic liver failure: The RELIEF trial (2013) (443)
- Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage. (2006) (440)
- Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study. (1987) (433)
- Tumor necrosis factor and interleukin‐6 in spontaneous bacterial peritonitis in cirrhosis: Relationship with the development of renal impairment and mortality (1998) (418)
- Mechanisms of decompensation and organ failure in cirrhosis: From peripheral arterial vasodilation to systemic inflammation hypothesis. (2015) (398)
- Recurrence of spontaneous bacterial peritonitis in cirrhosis: Frequency and predictive factors (1988) (398)
- Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis (2003) (390)
- Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: Effects on renal function and vasoactive systems (1998) (378)
- Working Party proposal for a revised classification system of renal dysfunction in patients with cirrhosis (2011) (370)
- Resolvin D1 and Its Precursor Docosahexaenoic Acid Promote Resolution of Adipose Tissue Inflammation by Eliciting Macrophage Polarization toward an M2-Like Phenotype (2011) (369)
- Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome. (2000) (366)
- Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study. (2008) (358)
- A histologic scoring system for prognosis of patients with alcoholic hepatitis. (2014) (337)
- Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II. (2003) (332)
- Human serum albumin, systemic inflammation, and cirrhosis. (2014) (328)
- Role for PPARγ in obesity‐induced hepatic steatosis as determined by hepatocyte‐ and macrophage‐specific conditional knockouts (2011) (327)
- MELD score and clinical type predict prognosis in hepatorenal syndrome: Relevance to liver transplantation (2005) (326)
- Bacterial and fungal infections in acute-on-chronic liver failure: prevalence, characteristics and impact on prognosis (2017) (324)
- Acute-on-chronic liver failure: A new syndrome that will re-classify cirrhosis. (2015) (323)
- Albumin: Pathophysiologic basis of its role in the treatment of cirrhosis and its complications (2013) (316)
- Prognostic importance of the cause of renal failure in patients with cirrhosis. (2011) (315)
- Cefotaxime is more effective than is ampicillin‐tobramycin in cirrhotics with severe infections (1985) (311)
- Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites. (1991) (290)
- Paracentesis-induced circulatory dysfunction: mechanism and effect on hepatic hemodynamics in cirrhosis. (1997) (288)
- Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion (1998) (287)
- Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis. (2003) (282)
- Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management. (2003) (274)
- Adrenal insufficiency in patients with cirrhosis and septic shock: Effect of treatment with hydrocortisone on survival (2006) (273)
- A prognostic model for predicting survival in cirrhosis with ascites. (2001) (268)
- A New Scoring System for Prognostic Stratification of Patients With Alcoholic Hepatitis (2008) (266)
- Renal failure after upper gastrointestinal bleeding in cirrhosis: Incidence, clinical course, predictive factors, and short‐term prognosis (2001) (261)
- Antiangiogenic treatment with Sunitinib ameliorates inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats (2007) (261)
- Acute-on-chronic liver failure in cirrhosis (2016) (258)
- Renal failure in patients with cirrhosis and sepsis unrelated to spontaneous bacterial peritonitis: value of MELD score. (2005) (255)
- Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis (2002) (254)
- The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure. (2015) (251)
- Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF). (2014) (248)
- Oral, nonabsorbable antibiotics prevent infection in cirrhotics with gastrointestinal hemorrhage (1985) (245)
- Intensive care of the patient with cirrhosis (2011) (236)
- Systemic inflammatory response and serum lipopolysaccharide levels predict multiple organ failure and death in alcoholic hepatitis (2015) (226)
- Toward an improved definition of acute-on-chronic liver failure. (2014) (224)
- Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites (2015) (223)
- Hyponatremia Is a Risk Factor of Hepatic Encephalopathy in Patients With Cirrhosis: A Prospective Study With Time-Dependent Analysis (2009) (222)
- Endogenous cannabinoids: a new system involved in the homeostasis of arterial pressure in experimental cirrhosis in the rat. (2002) (219)
- A randomized unblinded pilot study comparing albumin versus hydroxyethyl starch in spontaneous bacterial peritonitis (2005) (216)
- Spontaneous bacterial peritonitis in cirrhosis: Predictive factors of infection resolution and survival in patients treated with cefotaxime (1993) (216)
- Effects of treatment of hepatorenal syndrome before transplantation on posttransplantation outcome. A case-control study. (2004) (215)
- Docosahexaenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators: protectin D1 and 17S‐hydroxy‐DHA (2006) (214)
- Sympathetic nervous activity, renin‐angiotensin system and renal excretion of prostaglandin E2 in cirrhosis. Relationship to functional renal failure and sodium and water excretion (1983) (210)
- Incidence and predictive factors of first episode of spontaneous bacterial peritonitis in cirrhosis with ascites: Relevance of ascitic fluid protein concentration (1992) (209)
- Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites: Relationship between the diuretic response and the activity of the renin-aldosterone system (1983) (205)
- Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis. (2009) (204)
- Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndrome (2010) (202)
- Relation of renal impairment and haemorrhagic diathesis to endotoxaemia in fulminant hepatic failure. (1974) (199)
- Pathogenesis of arterial hypotension in cirrhotic rats with ascites: Role of endogenous nitric oxide (1992) (196)
- Circulating levels of endothelin in cirrhosis. (1993) (196)
- Pathogenesis and treatment of hepatorenal syndrome. (2008) (194)
- Total paracentesis associated with intravenous albumin management of patients with cirrhosis and ascites. (1990) (187)
- Albumin for bacterial infections other than spontaneous bacterial peritonitis in cirrhosis. A randomized, controlled study. (2012) (184)
- Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe. (2019) (183)
- Treatment with non-selective beta blockers is associated with reduced severity of systemic inflammation and improved survival of patients with acute-on-chronic liver failure. (2016) (182)
- Complications of cirrhosis. II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem. (2000) (181)
- Hyponatremia impairs early posttransplantation outcome in patients with cirrhosis undergoing liver transplantation. (2006) (180)
- Urinary neutrophil gelatinase-associated lipocalin as biomarker in the differential diagnosis of impairment of kidney function in cirrhosis. (2012) (179)
- Impaired responsiveness to angiotensin II in experimental cirrhosis: Role of nitric oxide (1993) (179)
- Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: Results of a prospective, randomized, multicenter study (1995) (177)
- Hepatic hemodynamics and the renin-angiotensin-aldosterone system in cirrhosis (1980) (173)
- Liver progenitor cell markers correlate with liver damage and predict short‐term mortality in patients with alcoholic hepatitis (2012) (171)
- MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation (2007) (171)
- Transcriptome analysis identifies TNF superfamily receptors as potential therapeutic targets in alcoholic hepatitis (2012) (168)
- Brachial and femoral artery blood flow in cirrhosis: Relationship to kidney dysfunction (1993) (167)
- Regression of Fibrosis after Chronic Stimulation of Cannabinoid CB2 Receptor in Cirrhotic Rats (2008) (167)
- Dextran-70 versus albumin as plasma expanders in cirrhotic patients with tense ascites treated with total paracentesis. Results of a randomized study. (1990) (166)
- Inhibition of soluble epoxide hydrolase modulates inflammation and autophagy in obese adipose tissue and liver: Role for omega-3 epoxides (2014) (166)
- The biliary epithelium gives rise to liver progenitor cells (2014) (157)
- Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis. (1996) (155)
- Aminoglycoside nephrotoxicity in cirrhosis: Value of urinary β2-microglobulin to discriminate functional renal failure from acute tubular damage (1982) (155)
- Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF. (2019) (152)
- Increased cerebrovascular resistance in cirrhotic patients with ascites (1998) (152)
- Atrial natriuretic factor in cirrhosis with ascites: Plasma levels, cardiac release and splanchnic extraction (1988) (150)
- Advances in the pathogenesis and treatment of type-1 and type-2 hepatorenal syndrome. (2007) (146)
- The PREDICT study uncovers three clinical courses in acutely decompensated cirrhosis with distinct pathophysiology (120/120). (2020) (146)
- Effect of angiotensin‐ll blockade on systemic and hepatic haemodynamics and on the renin‐angiotensin‐aldosterone system in cirrhosis with ascites (1981) (146)
- Acute kidney injury is an early predictor of mortality for patients with alcoholic hepatitis. (2012) (145)
- Hepatorenal syndrome in cirrhosis: pathogenesis and treatment. (2002) (144)
- Ghrelin attenuates hepatocellular injury and liver fibrogenesis in rodents and influences fibrosis progression in humans (2010) (143)
- 5-Lipoxygenase Activating Protein Signals Adipose Tissue Inflammation and Lipid Dysfunction in Experimental Obesity (2010) (143)
- Effect of intravenous albumin on systemic and hepatic hemodynamics and vasoactive neurohormonal systems in patients with cirrhosis and spontaneous bacterial peritonitis. (2004) (142)
- Prognostic value of spontaneous hyponatremia in cirrhosis with ascites (1976) (141)
- Human hepatic stellate cells show features of antigen-presenting cells and stimulate lymphocyte proliferation. (2003) (136)
- Albumin in decompensated cirrhosis: new concepts and perspectives (2020) (130)
- Reduction of advanced liver fibrosis by short‐term targeted delivery of an angiotensin receptor blocker to hepatic stellate cells in rats (2010) (130)
- Effects of Albumin Treatment on Systemic and Portal Hemodynamics and Systemic Inflammation in Patients With Decompensated Cirrhosis. (2019) (129)
- Increased nitric oxide synthase expression in arterial vessels of cirrhotic rats with ascites. (1996) (129)
- Renal function abnormalities, prostaglandins, and effects of nonsteroidal anti-inflammatory drugs in cirrhosis with ascites. An overview with emphasis on pathogenesis. (1986) (127)
- Transduction of the liver with activated Akt normalizes portal pressure in cirrhotic rats. (2003) (125)
- The hepatic apelin system: A new therapeutic target for liver disease (2008) (125)
- Cigarette smoking exacerbates nonalcoholic fatty liver disease in obese rats (2010) (124)
- LEFT ventricular function assessed by echocardiography in cirrhosis: relationship to systemic hemodynamics and renal dysfunction. (2013) (124)
- The selective cyclooxygenase‐2 inhibitor SC‐236 reduces liver fibrosis by mechanisms involving non‐parenchymal cell apoptosis and PPARγ activation (2005) (124)
- Evidence that renal prostaglandins are involved in renal water metabolism in cirrhosis. (1984) (123)
- CCL20 mediates lipopolysaccharide induced liver injury and is a potential driver of inflammation and fibrosis in alcoholic hepatitis (2014) (123)
- Effects of low‐sodium diet and spironolactone on portal pressure in patients with compensated cirrhosis (1994) (123)
- Restricted use of albumin for spontaneous bacterial peritonitis (2007) (122)
- Diagnosis of functional kidney failure of cirrhosis with Doppler sonography: Prognostic value of resistive index (1994) (121)
- Characteristics, Diagnosis and Prognosis of Acute-on-Chronic Liver Failure in Cirrhosis Associated to Hepatitis B. (2016) (121)
- Temporal relationship between hyperaldosteronism, sodium retention and ascites formation in rats with experimental cirrhosis (1985) (121)
- Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis (1996) (121)
- Relative adrenal insufficiency in decompensated cirrhosis: Relationship to short‐term risk of severe sepsis, hepatorenal syndrome, and death (2013) (120)
- Hepatic expression of candidate genes in patients with alcoholic hepatitis: correlation with disease severity. (2007) (119)
- Acute-on-Chronic Liver Failure. (2020) (119)
- Molecular interplay between Δ5/Δ6 desaturases and long-chain fatty acids in the pathogenesis of non-alcoholic steatohepatitis (2013) (114)
- Role of albumin in diseases associated with severe systemic inflammation: Pathophysiologic and clinical evidence in sepsis and in decompensated cirrhosis. (2016) (114)
- The Systemic Inflammation Hypothesis: Towards a New Paradigm of Acute Decompensation and Multiorgan Failure in Cirrhosis. (2020) (114)
- Factors related to quality of life in patients with cirrhosis and ascites: relevance of serum sodium concentration and leg edema. (2012) (112)
- Ascites and Renal Dysfunction in Liver Disease (2005) (111)
- PARACENTESIS VERSUS DIURETICS IN THE TREATMENT OF CIRRHOTICS WITH TENSE ASCITES (1985) (110)
- Renin, aldosterone and renal haemodynamics in cirrhosis with ascites (1979) (108)
- Effects of losartan on hepatic expression of nonphagocytic NADPH oxidase and fibrogenic genes in patients with chronic hepatitis C. (2009) (108)
- Acetylsalicylic acid suppresses the renal hemodynamic effect and reduces the diuretic action of furosemide in cirrhosis with ascites. (1983) (107)
- Risk factors for hepatic encephalopathy in patients with cirrhosis and refractory ascites: relevance of serum sodium concentration (2010) (105)
- Spontaneous bacterial peritonitis in patients with cirrhosis undergoing selective intestinal decontamination. A retrospective study of 229 spontaneous bacterial peritonitis episodes. (1997) (105)
- Increased anandamide induced relaxation in mesenteric arteries of cirrhotic rats: role of cannabinoid and vanilloid receptors (2005) (104)
- Neutrophil gelatinase-associated lipocalin is a biomarker of acute-on-chronic liver failure and prognosis in cirrhosis. (2016) (103)
- Association Between Grade of Acute on Chronic Liver Failure and Response to Terlipressin and Albumin in Patients With Hepatorenal Syndrome (2018) (103)
- Plasma renin activity and urinary sodium excretion as prognostic indicators in nonazotemic cirrhosis with ascites. (1981) (103)
- Nitric oxide production in arterial vessels of cirrhotic rats (1995) (102)
- PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis. (2020) (98)
- Addressing Profiles of Systemic Inflammation Across the Different Clinical Phenotypes of Acutely Decompensated Cirrhosis (2019) (98)
- Terlipressin and albumin for type-1 hepatorenal syndrome associated with sepsis. (2014) (97)
- Functional renal failure and haemorrhagic gastritis associated with endotoxaemia in cirrhosis. (1977) (97)
- Antidiuretic hormone and the pathogenesis of water retention in cirrhosis with ascites. (1994) (96)
- Pathogenesis of ascites in cirrhosis. (1987) (96)
- Cerebral magnetic resonance imaging reveals marked abnormalities of brain tissue density in patients with cirrhosis without overt hepatic encephalopathy. (2011) (94)
- Atorvastatin attenuates angiotensin II-induced inflammatory actions in the liver. (2009) (93)
- Hyponatremia in patients treated with terlipressin for severe gastrointestinal bleeding due to portal hypertension (2010) (93)
- Increased adrenomedullin levels in cirrhosis: relationship with hemodynamic abnormalities and vasoconstrictor systems. (1998) (93)
- Human hepatic stellate cells show features of antigen‐presenting cells and stimulate lymphocyte proliferation (2003) (93)
- Resolvin D1 primes the resolution process initiated by calorie restriction in obesity‐induced steatohepatitis (2014) (92)
- Gene Expression of Endothelin-1 and ETA and ETB Receptors in Human Cirrhosis: Relationship with Hepatic Hemodynamics (1998) (92)
- Urinary excretion of 6-keto-prostaglandin F1 alpha, thromboxane B2 and prostaglandin E2 in cirrhosis with ascites. Relationship to functional renal failure (hepatorenal syndrome). (1986) (91)
- Acute kidney injury and acute-on-chronic liver failure classifications in prognosis assessment of patients with acute decompensation of cirrhosis (2014) (91)
- Analysis of a Urinary Biomarker Panel for Clinical Outcomes Assessment in Cirrhosis (2015) (90)
- Hepatic hemodynamics and the renin-angiotensin-aldosterone system in cirrhosis. (1980) (89)
- Carbon tetrachloride induced cirrhosis in rats: A useful tool for investigating the pathogenesis of ascites in chronic liver disease (1992) (88)
- Macrophage activation markers predict mortality in patients with liver cirrhosis without or with acute-on-chronic liver failure (ACLF). (2016) (88)
- Renal failure after upper gastrointestinal bleeding in cirrhosis. Incidence, clinical course, predictive factors and short-term prognosis (2001) (88)
- Favorable effects of total paracentesis on splanchnic hemodynamics in cirrhotic patients with tense ascites (1994) (88)
- 5‐lipoxygenase deficiency reduces hepatic inflammation and tumor necrosis factor α–induced hepatocyte damage in hyperlipidemia‐prone ApoE‐null mice (2010) (85)
- Human and experimental evidence supporting a role for osteopontin in alcoholic hepatitis (2013) (85)
- Genomic and functional characterization of stellate cells isolated from human cirrhotic livers. (2005) (85)
- Increased nitric oxide—dependent vasorelaxation in aortic rings of cirrhotic rats with ascites (1994) (85)
- The Acute-on-Chronic Liver Failure Syndrome, or When the Innate Immune System Goes Astray (2016) (84)
- Effects of celecoxib and naproxen on renal function in nonazotemic patients with cirrhosis and ascites (2005) (83)
- Urinary neutrophil gelatinase-associated lipocalin predicts kidney outcome and death in patients with cirrhosis and bacterial infections. (2014) (81)
- Beneficial effects of intravenous albumin infusion on the hemodynamic and humoral changes after total paracentesis (1995) (81)
- Signaling and Immunoresolving Actions of Resolvin D1 in Inflamed Human Visceral Adipose Tissue (2016) (81)
- Renal effects of acute isosorbide‐5‐mononitrate administration in cirrhosis (1993) (80)
- Comparison of Paracentesis and Diuretics in the Treatment of Cirrhotics With Tense Ascites (1987) (79)
- Dysregulation of renal aquaporins and Na-Cl cotransporter in CCl4-induced cirrhosis. (2000) (78)
- Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites. Relationship between the diuretic response and the activity of the renin-aldosterone system. (1983) (78)
- The selective cyclooxygenase-2 inhibitor SC-236 reduces liver fibrosis by mechanisms involving non-parenchymal cell apoptosis and PPARgamma activation. (2005) (77)
- Inhibition of 5‐lipoxygenase induces cell growth arrest and apoptosis in rat Kupffer cells: implications for liver fibrosis (2003) (77)
- Chronic blockade of endothelin receptors in cirrhotic rats: hepatic and hemodynamic effects. (1999) (77)
- Total paracentesis with dextran 40 vs diuretics in the treatment of ascites in cirrhosis: a randomized controlled study. (1994) (77)
- Severe ovarian hyperstimulation syndrome: Role of peripheral vasodilation (1991) (77)
- Diuretic requirements after therapeutic paracentesis in non-azotemic patients with cirrhosis. A randomized double-blind trial of spironolactone versus placebo. (1997) (77)
- Hepatocyte-derived cysteinyl leukotrienes modulate vascular tone in experimental cirrhosis. (2000) (77)
- Cell-specific PPARγ deficiency establishes anti-inflammatory and anti-fibrogenic properties for this nuclear receptor in non-parenchymal liver cells. (2013) (77)
- Ascites and Renal Dysfunction in Liver Disease: Pathogenesis, Diagnosis, and Treatment (1999) (76)
- Arginine vasopressin induces contraction and stimulates growth of cultured human hepatic stellate cells. (1997) (75)
- Acute‐on‐Chronic Liver Failure: Getting Ready for Prime Time? (2018) (75)
- Increased carbon monoxide production in patients with cirrhosis with and without spontaneous bacterial peritonitis (2003) (74)
- Vascular endothelial growth factor production in peritoneal macrophages of cirrhotic patients: Regulation by cytokines and bacterial lipopolysaccharide (1999) (74)
- Mechanisms of water and sodium retention in cirrhosis and the pathogenesis of ascites. (2003) (74)
- Beneficial effects of intravenous albumin infusion on the hemodynamic and humoral changes after total paracentesis. (1995) (73)
- Increased susceptibility to exacerbated liver injury in hypercholesterolemic ApoE-deficient mice: potential involvement of oxysterols. (2009) (73)
- Renal sodium retention in cirrhosis: relation to aldosterone and nephron site. (1979) (72)
- Acute-on-Chronic Liver Failure: Definition, Diagnosis, and Clinical Characteristics (2016) (71)
- Effect of V1-vasopressin receptor blockade on arterial pressure in conscious rats with cirrhosis and ascites. (1991) (71)
- Altered biosynthesis of leukotrienes and lipoxins and host defense disorders in patients with cirrhosis and ascites. (1998) (70)
- Oral misoprostol or intravenous prostaglandin E2 do not improve renal function in patients with cirrhosis and ascites with hyponatremia or renal failure. (1993) (70)
- Renal failure associated with demeclocycline in cirrhosis. (1977) (70)
- Role of nitric oxide and prostacyclin in the control of renal perfusion in experimental cirrhosis (1995) (69)
- Type‐1 hepatorenal syndrome associated with infections in cirrhosis: Natural history, outcome of kidney function, and survival (2014) (69)
- Inhibition of 5‐lipoxygenase‐activating protein abrogates experimental liver injury: role of Kupffer cells (2005) (69)
- Sulindac reduces the urinary excretion of prostaglandins and impairs renal function in cirrhosis with ascites. (1986) (68)
- Aspirin (ASA) regulates 5‐lipoxygenase activity and peroxisome proliferator‐activated receptor α‐mediated CINC‐1 release in rat liver cells: novel actions of lipoxin A4 (LXA4) and ASA‐triggered 15‐epi‐LXA4 (2002) (68)
- Renal hemodynamic abnormalities in patients with short term insulin-dependent diabetes mellitus: role of renal prostaglandins. (1985) (68)
- Nitric oxide synthase 3-dependent vascular remodeling and circulatory dysfunction in cirrhosis. (2003) (67)
- A rational approach to the treatment of ascites (1975) (67)
- Coordinate Functional Regulation between Microsomal Prostaglandin E Synthase-1 (mPGES-1) and Peroxisome Proliferator-activated Receptor γ (PPARγ) in the Conversion of White-to-brown Adipocytes* (2013) (67)
- In vitro and in vivo activation of rat hepatic stellate cells results in de novo expression of L‐type voltage‐operated calcium channels (2001) (66)
- Treatment of patients with cirrhosis and refractory ascites using LeVeen shunt with titanium tip: Comparison with therapeutic paracentesis (1995) (66)
- Sarcopenia Is Associated With Development of Acute-on-Chronic Liver Failure in Decompensated Liver Cirrhosis Receiving Transjugular Intrahepatic Portosystemic Shunt (2019) (65)
- Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites (1983) (65)
- Assessment of the renin-angiotensin system in cirrhotic patients. Comparison between plasma renin activity and direct measurement of immunoreactive renin. (1992) (65)
- Plasma cystatin C is a predictor of renal dysfunction, acute‐on‐chronic liver failure, and mortality in patients with acutely decompensated liver cirrhosis (2017) (64)
- Pathophysiology of ascites and functional renal failure in cirrhosis. (1988) (64)
- Effects of dilutional hyponatremia on brain organic osmolytes and water content in patients with cirrhosis (2004) (64)
- Neurohormonal and Hemodynamic Changes in Severe Cases of the Ovarian Hyperstimulation Syndrome (1994) (63)
- Orchestration of Tryptophan‐Kynurenine Pathway, Acute Decompensation, and Acute‐on‐Chronic Liver Failure in Cirrhosis (2019) (62)
- Aminoglycoside nephrotoxicity in cirrhosis. Value of urinary beta 2-microglobulin to discriminate functional renal failure from acute tubular damage. (1982) (62)
- Effects of contrast media on renal function in patients with cirrhosis: A prospective study (2004) (62)
- Acute-on-chronic liver failure: a new clinical entity. (2015) (62)
- Efficacy of Albumin Treatment for Patients with Cirrhosis and Infections Unrelated to Spontaneous Bacterial Peritonitis. (2020) (62)
- Blockade of the hydroosmotic effect of vasopressin normalizes water excretion in cirrhotic rats. (1989) (61)
- Frequency of renal impairment in paracetamol overdose compared with other causes of acute liver damage. (1977) (61)
- Selective intestinal decontamination in the prevention of bacterial infection in patients with acute liver failure. (1992) (61)
- Peripheral arterial vasodilation hypothesis: a new insight into the pathogenesis of ovarian hyperstimulation syndrome. (1998) (60)
- Norepinephrine induces calcium spikes and proinflammatory actions in human hepatic stellate cells. (2006) (59)
- Comparative Protection against Liver Inflammation and Fibrosis by a Selective Cyclooxygenase-2 Inhibitor and a Nonredox-Type 5-Lipoxygenase Inhibitor (2007) (58)
- Renal and neurohormonal changes following simultaneous administration of systemic vasoconstrictors and dopamine or prostacyclin in cirrhotic patients with hepatorenal syndrome. (1996) (58)
- Selective inhibition of cyclooxygenase 2 spares renal function and prostaglandin synthesis in cirrhotic rats with ascites. (1999) (57)
- Management of hepatorenal syndrome in patients with cirrhosis (2011) (56)
- Clinical types and drug therapy of renal impairment in cirrhosis (1975) (56)
- The prognostic value of acute-on-chronic liver failure during the course of severe alcoholic hepatitis. (2018) (54)
- Acute prerenal failure and liver dysfunction in a patient with severe ovarian hyperstimulation syndrome. (1990) (54)
- Disruption of the 12/15‐lipoxygenase gene (Alox15) protects hyperlipidemic mice from nonalcoholic fatty liver disease (2010) (53)
- Effect of therapeutic paracentesis on plasma volume and transvascular escape rate of albumin in patients with cirrhosis. (1997) (53)
- Contraction of human hepatic stellate cells activated in culture: a role for voltage-operated calcium channels. (1998) (53)
- Endothelin 1 does not play a major role in the homeostasis of arterial pressure in cirrhotic rats with ascites. (1995) (53)
- Renal Kallikrein Excretion in Cirrhotics with Ascites: Relationship to Renal Hemodynamics (1984) (52)
- Treatment of type 2 hepatorenal syndrome in patients awaiting transplantation: Effects on kidney function and transplantation outcomes (2015) (52)
- Effects of somatostatin on renal function in cirrhosis. (1992) (50)
- Cyclooxygenase‐1 derived prostaglandins are involved in the maintenance of renal function in rats with cirrhosis and ascites (2002) (50)
- Aquaporin‐1 and aquaporin‐2 urinary excretion in cirrhosis: Relationship with ascites and hepatorenal syndrome (2006) (49)
- Hepatorenal syndrome. (2003) (49)
- Intrarenal distribution of plasma flow in cirrhosis as measured by transit renography: relationship with plasma renin activity, and sodium and water excretion. (1977) (49)
- Nitric oxide production and inducible nitric oxide synthase expression in peritoneal macrophages of cirrhotic patients (1999) (48)
- Inhibition of angiotensin II action protects rat steatotic livers against ischemia-reperfusion injury (2008) (48)
- Effects of dilutional hyponatremia on brain organic osmolytes and water content in patients with cirrhosis. (2004) (48)
- Hepatocarcinoma cells stimulate the growth, migration and expression of pro‐angiogenic genes in human hepatic stellate cells (2010) (47)
- Aquaretic effect of the kappa-opioid agonist RU 51599 in cirrhotic rats with ascites and water retention. (1995) (47)
- Severe acute kidney injury associated with non-steroidal anti-inflammatory drugs in cirrhosis: A case-control study. (2015) (47)
- Reply to: Correspondence on 'The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology'. (2020) (47)
- Renal failure and hyponatremia in patients with cirrhosis and skin and soft tissue infection. A retrospective study. (2012) (46)
- Oxidized Albumin Triggers a Cytokine Storm in Leukocytes Through P38 Mitogen‐Activated Protein Kinase: Role in Systemic Inflammation in Decompensated Cirrhosis (2018) (46)
- Impact of shunt surgery for variceal bleeding in the natural history of ascites in cirrhosis: A retrospective study (1994) (46)
- Increased plasma endothelin in cirrhosis. Relationship with systemic endotoxemia and response to changes in effective blood volume. (1995) (46)
- Pathophysiology, diagnosis and treatment of ascites in cirrhosis. (2000) (45)
- A European survey on the treatment of ascites in cirrhosis. (1994) (45)
- Temporal relationship between the decrease in arterial pressure and sodium retention in conscious spontaneously hypertensive rats with carbon tetrachloride–induced cirrhosis (1991) (45)
- Increased nitric oxide production in lymphatic endothelial cells causes impairment of lymphatic drainage in cirrhotic rats (2012) (44)
- Lactitol versus lactulose in the treatment of acute portal systemic encephalopathy (PSE). A controlled trial. (1987) (44)
- Management of ascites and hepatic hydrothorax. (2007) (44)
- Review article: albumin in the treatment of liver diseases—new features of a classical treatment (2002) (44)
- Renal effects of natriuretic peptide receptor blockade in cirrhotic rats with ascites (1994) (44)
- Effect of bacterial lipopolysaccharide on endothelin-1 production in human vascular endothelial cells. (1997) (44)
- Effect of upright posture and physical exercise on endogenous neurohormonal systems in cirrhotic patients with sodium retention and normal supine plasma renin, aldosterone, and norepinephrine levels (1995) (44)
- Differential inflammasome activation predisposes to acute-on-chronic liver failure in human and experimental cirrhosis with and without previous decompensation (2020) (43)
- Mineralocorticoid escape in patients with compensated cirrhosis and portal hypertension. (1992) (43)
- Are Angiotensin II Receptor Antagonists Useful Strategies in Steatotic and Nonsteatotic Livers in Conditions of Partial Hepatectomy under Ischemia-Reperfusion? (2009) (43)
- Effect of Dipyridamole on Kidney Function in Cirrhosis (1993) (43)
- Temporal relationship between the impairment of free water excretion and antidiuretic hormone hypersecretion in rats with experimental cirrhosis. (1987) (42)
- Impairment of renal function during moderate physical exercise in cirrhotic patients with ascites: Relationship with the activity of neurohormonal systems (1997) (42)
- Management of ascites and renal failure in cirrhosis. (1994) (42)
- Effect of the V1a/V2-AVP receptor antagonist, Conivaptan, on renal water metabolism and systemic hemodynamics in rats with cirrhosis and ascites. (2003) (42)
- Bradykinin attenuates hepatocellular damage and fibrosis in rats with chronic liver injury. (2007) (42)
- Hyponatremia influences the outcome of patients with acute-on-chronic liver failure: an analysis of the CANONIC study (2014) (42)
- Management of patients with cirrhosis and ascites. (1986) (41)
- Hepatorenal syndrome. (2003) (41)
- Clinical course and short‐term mortality of cirrhotic patients with infections other than spontaneous bacterial peritonitis (2017) (40)
- Mechanisms of ascites formation. (2000) (40)
- Molecular Adsorbent Recirculating System Can Reduce Short-Term Mortality Among Patients With Acute-on-Chronic Liver Failure—A Retrospective Analysis* (2017) (40)
- Increased production of vascular endothelial growth factor in peritoneal macrophages of cirrhotic patients with spontaneous bacterial peritonitis (2001) (40)
- Microarray analysis of endothelial differentially expressed genes in liver of cirrhotic rats. (2005) (40)
- Refractory Ascites (2005) (40)
- Cell death markers in cirrhotic patients with acute decompensation (2017) (40)
- Circulatory dysfunction in asymptomatic in vitro fertilization patients. Relationship with hyperestrogenemia and activity of endogenous vasodilators. (1998) (39)
- Hypoxia is an inducer of vasodilator agents in peritoneal macrophages of cirrhotic patients (2002) (39)
- Treatment of ascites in cirrhosis. Diuretics, peritoneovenous shunt, and large-volume paracentesis. (1992) (39)
- Comparison of two aquaretic drugs (niravoline and OPC-31260) in cirrhotic rats with ascites and water retention. (1999) (39)
- Review article: albumin for circulatory support in patients with cirrhosis (2002) (39)
- Acute-on-Chronic Liver Failure: Recent Concepts. (2015) (39)
- Effect of demeclocycline on renal function and urinary prostaglandin E2 and kallikrein in hyponatremic cirrhotics. (1984) (39)
- Cell death markers in patients with cirrhosis and acute decompensation (2018) (39)
- Long-term aquaretic efficacy of a selective nonpeptide V(2)-vasopressin receptor antagonist, SR121463, in cirrhotic rats. (2000) (38)
- Ascites and liver test abnormalities during severe ovarian hyperstimulation syndrome (1999) (38)
- Haematocrit, leukocyte and platelet counts and the severity of the ovarian hyperstimulation syndrome. (1998) (38)
- Abnormalities of sodium excretion and other disorders of renal function in fulminant hepatic failure. (1976) (37)
- Liver Transplantation for Acute‐on‐Chronic Liver Failure: Science or Fiction? (2020) (36)
- Refractory ascites in cirrhosis: Mechanism and treatment (1989) (36)
- Sodium retention in cirrhotic rats is associated with increased renal abundance of sodium transporter proteins. (2005) (36)
- Acute kidney injury (AKI) in cirrhosis: should we change current definition and diagnostic criteria of renal failure in cirrhosis? (2013) (36)
- Arteriolar vasodilation and the pathogenesis of the hyperdynamic circulation and renal sodium and water retention in cirrhosis. (1992) (35)
- Albumin internalizes and inhibits endosomal TLR signaling in leukocytes from patients with decompensated cirrhosis (2020) (35)
- Hepatorenal syndrome: definition, pathophysiology, clinical features and management. (1998) (35)
- Mechanism of sodium retention and ascites formation in cirrhosis. (1993) (34)
- [82] RANDOMIZED, COMPARATIVE STUDY OF TERLIPRESSIN AND ALBUMIN VS ALBUMIN ALONE IN PATIENTS WITH CIRRHOSIS AND HEPATORENAL SYNDROME (2007) (34)
- Is there still a need for albumin infusions to treat patients with liver disease? (2000) (34)
- Renal insensitivity to atrial natriuretic peptide in patients with cirrhosis and ascites: Effect of increasing systemic arterial pressure (1992) (33)
- The kidney in liver disease (1998) (33)
- Hemodynamic changes induced by urinary human chorionic gonadotropin and recombinant luteinizing hormone used for inducing final follicular maturation and luteinization. (2002) (33)
- Pathophysiology, diagnosis and treatment of ascites in cirrhosis. (2002) (33)
- Dynamic Prognostication in Critically Ill Cirrhotic Patients With Multiorgan Failure in ICUs in Europe and North America: A Multicenter Analysis* (2018) (33)
- The role of nitric oxide in the pathogenesis of systemic and splanchnic vasodilation in cirrhotic rats before and after the onset of ascites (2005) (33)
- Atrial natriuretic peptide antagonizes endothelin‐induced calcium increase and cell contraction in cultured human hepatic stellate cells (1999) (32)
- Polymorphisms in the IL‐1 gene cluster influence systemic inflammation in patients at risk for acute‐on‐chronic liver failure (2017) (32)
- Bacterial infections in cirrhosis: A growing problem with significant implications (2013) (32)
- Paracentesis in the management of cirrhotic ascites. (1993) (31)
- The Amount of Alcohol Consumption Negatively Impacts Short-Term Mortality in Mexican Patients With Alcoholic Hepatitis (2011) (31)
- Spontaneous bacterial peritonitis in cirrhotic patients treated using paracentesis or diuretics: Results of a randomized study (1995) (30)
- 6 CURRENT EFFICACY OF RECOMMENDED EMPIRICAL ANTIBIOTIC THERAPY IN PATIENTS WITH CIRRHOSIS AND BACTERIAL INFECTION (2009) (30)
- New treatments for hepatorenal syndrome (2000) (29)
- Meta-analysis of individual patient data of albumin dialysis in acute-on-chronic liver failure: focus on treatment intensity (2019) (29)
- Plasma Exchange: An Effective Rescue Therapy in Critically Ill Patients With Coronavirus Disease 2019 Infection (2020) (29)
- Targeted lipidomics reveals extensive changes in circulating lipid mediators in patients with acutely decompensated cirrhosis. (2020) (28)
- Pathophysiological basis of albumin use in cirrhosis. (2011) (28)
- Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. (2007) (28)
- Human myofibroblastic hepatic stellate cells express Ca(2+)-activated K(+) channels that modulate the effects of endothelin-1 and nitric oxide. (2001) (28)
- High-density lipoproteins reduce the effect of endotoxin on cytokine production and systemic hemodynamics in cirrhotic rats with ascites. (2004) (28)
- Nitric oxide production by peritoneal macrophages of cirrhotic rats: a host response against bacterial peritonitis. (1997) (28)
- Doses of endothelin have natriuretic effects in conscious rats with cirrhosis and ascites. (1991) (27)
- Human hepatic stellate cells secrete adrenomedullin: potential autocrine factor in the regulation of cell contractility. (2001) (27)
- Role of altered systemic hemodynamics in the blunted renal response to atrial natriuretic peptide in rats with cirrhosis and ascites. (1989) (27)
- Pathogenesis, Diagnosis and Treatment of Ascites in Cirrhosis (2008) (26)
- Trends and the course of liver cirrhosis and its complications in Germany: Nationwide population-based study (2005 to 2018) (2021) (25)
- HS-142-1, a potent antagonist of natriuretic peptides in vitro and in vivo. (1994) (25)
- Left Ventricular Longitudinal Contractility Predicts Acute‐on‐Chronic Liver Failure Development and Mortality After Transjugular Intrahepatic Portosystemic Shunt (2019) (23)
- Treatment of severe ovarian hyperstimulation syndrome by a conservative medical approach (1996) (23)
- New treatments of hepatorenal syndrome. (2006) (23)
- Protection from hepatic lipid accumulation and inflammation by genetic ablation of 5-lipoxygenase. (2010) (23)
- Pathogenesis of ascites in cirrhosis. (1987) (23)
- Urinary excretion of urodilatin in patients with cirrhosis (1996) (23)
- LPS-TLR4 Pathway Mediates Ductular Cell Expansion in Alcoholic Hepatitis (2016) (23)
- Increased plasma levels of neuropeptide Y in hepatorenal syndrome. (2002) (22)
- Experience with cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis. (1995) (22)
- Spontaneous bacterial peritonitis in liver cirrhosis: Treatment and prophylaxis (2005) (22)
- ERCP in orthotopic liver transplanted patients. (2004) (22)
- Diagnosis and prognosis of acute on chronic liver failure (ACLF) in cirrhosis. (2017) (22)
- New clinical and pathophysiological perspectives defining the trajectory of cirrhosis. (2021) (22)
- Mitochondrial dysfunction governs immunometabolism in leukocytes of patients with acute-on-chronic liver failure. (2021) (22)
- Assessing the role of amino acids in systemic inflammation and organ failure in patients with ACLF. (2020) (22)
- Prostaglandins and other cyclooxygenase-dependent arachidonic acid metabolites and the kidney in liver disease. (2003) (21)
- Acute-on-Chronic Liver Failure: A Distinct Clinical Condition (2016) (21)
- Molecular forms and biological activity of atrial natriuretic factor in patients with cirrhosis and ascites (1991) (21)
- Pathophysiology, complications, and treatment of ascites. (1997) (21)
- Characterization of Blood Immune Cells in Patients With Decompensated Cirrhosis Including ACLF (2021) (21)
- Matrix Metalloproteinase 2 in Reduced‐Size Liver Transplantation: Beyond the Matrix (2010) (20)
- TIPS and refractory ascites. Lessons from the recent history of ascites therapy. (1996) (20)
- The selective cyclooxygenase-2 inhibitor celecoxib modulates the formation of vasoconstrictor eicosanoids and activates PPARγ. Influence of albumin (2005) (20)
- 10 Ascites and renal functional abnormalities in cirrhosis. Pathogenesis and treatment (1997) (19)
- Endotoxin‐induced ascites formation in the rat: Partial mediation by platelet‐activating factor (1989) (19)
- Increased renal expression of nitric oxide synthase type III in cirrhotic rats with ascites (1998) (18)
- Prostaglandin precursor fatty acids in cirrhosis with ascites: effect of linoleic acid infusion in functional renal failure. (1988) (18)
- Effects of endothelin on renal haemodynamics and segmental sodium handling in conscious rats. (1991) (18)
- Effect of angiotensin II and bradykinin inhibition in rat reduced‐size liver transplantation (2009) (18)
- Use of piretanide, a new loop diuretic, in cirrhosis with ascites: relationship between the diuretic response and the plasma aldosterone level. (1980) (18)
- Intracellular calcium concentration in vascular smooth muscle cells of rats with cirrhosis. (1994) (18)
- Increased activity of guanosine 3′‐5′‐cyclic monophosphate phosphodiesterase in the renal tissue of cirrhotic rats with ascites (2000) (18)
- Chronology of hemodynamic changes in asymptomatic in vitro fertilization patients and relationship with ovarian steroids and cytokines. (2002) (17)
- Effects of intravenous amino acid infusion and dietary proteins on kidney function in cirrhosis (1990) (17)
- Kinase analysis in alcoholic hepatitis identifies p90RSK as a potential mediator of liver fibrogenesis (2015) (17)
- Radioimmunoassay for arginine-vasopressin in cold ethanol extracts of plasma. (1983) (17)
- Ascites from cirrhotic patients induces angiogenesis through the phosphoinositide 3-kinase/Akt signaling pathway. (2005) (16)
- Atrial natriuretic factor: reduced cardiac content in cirrhotic rats with ascites. (1986) (16)
- Gene Transduction of an Active Mutant of Akt Exerts Cytoprotection and Reduces Graft Injury After Liver Transplantation (2007) (16)
- 1404 DIAGNOSIS, PREVALENCE, AND PROGNOSIS OF ACUTE-ON- CHRONIC LIVER FAILURE (ACLF): RESULTS OF THE EASL-CHRONIC LIVER FAILURE (CLIF) CONSORTIUM CANONIC STUDY (2012) (16)
- Natriuretic hormone activity in the urine of cirrhotic patients (1990) (16)
- The Development and Outcome of Acute‐on‐Chronic Liver Failure After Surgical Interventions (2019) (15)
- Adrenomedullin and nitric oxide in menstrual and in vitro fertilization cycles. Relationship to estradiol (1999) (15)
- Longitudinal study of renal prostaglandin excretion in cirrhotic rats: relationship with the renin-aldosterone system. (1988) (15)
- Chemokine Receptor Ccr6 Deficiency Alters Hepatic Inflammatory Cell Recruitment and Promotes Liver Inflammation and Fibrosis (2015) (15)
- Combined liver-kidney transplantation in patients with cirrhosis and chronic kidney disease. (2010) (15)
- Sustained aquaretic effect of the V2‐AVP receptor antagonist, RWJ‐351647, in cirrhotic rats with ascites and water retention (2005) (15)
- Origins of cardiac dysfunction in cirrhosis (2003) (15)
- Renal failure in cirrhosis and liver transplantation. (1993) (15)
- Impaired extracellular matrix degradation in aortic vessels of cirrhotic rats. (2007) (14)
- Prostaglandins and the treatment of hepatorenal syndrome in cirrhosis. (1990) (14)
- Immunoreactive endothelin plasma levels in severe ovarian hyperstimulation syndrome. (1995) (14)
- Rectal colonization by resistant bacteria increases the risk of infection by the colonizing strain in critically ill patients with cirrhosis. (2022) (14)
- Pathogenesis of ascites and hepatorenal syndrome. (1991) (13)
- Effects of terlipressin administration with and without albumin in hepatorenal syndrome (HRS). A phase II study (2002) (13)
- Hepatorenal syndrome. (1997) (13)
- Diagnostic approach to the cirrhotic patient with ascites. (1996) (12)
- P476 SHORT-TERM (28-DAY) CLINICAL COURSE AND TRANSPLANT-FREE MORTALITY IN ACUTE ON CHRONIC LIVER FAILURE (ACLF); EVIDENCE FOR REVERSIBILITY OF ACLF (A STUDY FROM THE CANONIC DATABASE) (2014) (12)
- Pathogenesis of sodium retention in cirrhosis. (1993) (11)
- Use of albumin in the management of patients with decompensated cirrhosis. An independent verdict. (2003) (11)
- Treatment of ascites and renal failure in cirrhosis. (1989) (11)
- Hecker R, Sherlock S. Electrolyte and circulatory changes in terminal liver failure [Lancet 1956;2:1221-1225]. (2002) (11)
- Urinary endothelin-like immunoreactivity in patients with cirrhosis. (1997) (11)
- Comparative study of aminoglycoside nephrotoxicity in normal rats and rats with experimental cirrhosis (1988) (11)
- The use of human albumin in patients with cirrhosis: a European survey (2018) (10)
- Renal function abnormalities in cirrhosis (1991) (10)
- 146 PROGNOSTIC VALUE OF RELATIVE ADRENAL INSUFFICIENCY IN DECOMPENSATED CIRRHOSIS (2010) (10)
- Ascites and renal functional abnormalities in cirrhosis. Pathogenesis and treatment. (1997) (10)
- The Role of Macrophage-Inducible C-Type Lectin in Different Stages of Chronic Liver Disease (2020) (10)
- 80 ROLE FOR PPAR γ IN HEPATIC STEATOSIS AS DETERMINED BY HEPATOCYTE AND KUPFFER CELL-SPECIFIC CONDITIONAL KNOCKOUTS USING CRE RECOMBINASE (2010) (9)
- Microalbuminuria, systemic inflammation, and multiorgan dysfunction in decompensated cirrhosis: evidence for a nonfunctional mechanism of hepatorenal syndrome (2017) (9)
- 139 IMPACT OF RELATIVE ADRENAL INSUFFICIENCY ON CIRCULATORY FUNCTION AND MORTALITY IN ADVANCED CIRRHOSIS (2011) (9)
- Review of Defective NADPH Oxidase Activity and Myeloperoxidase Release in Neutrophils From Patients With Cirrhosis (2019) (9)
- Acute-on-Chronic Liver Failure in Cirrhosis Requires Expedited Decisions for Liver Transplantation. (2019) (9)
- Improved prediction of mortality by combinations of inflammatory markers and standard clinical scores in patients with acute‐on‐chronic liver failure and acute decompensation (2020) (9)
- Chronic Liver Failure (2011) (9)
- Acute‐on‐Chronic Liver Failure: A New Disease or an Old One Hiding in Plain Sight? (2020) (9)
- Tying up PGE2 with albumin to relieve immunosuppression in cirrhosis (2014) (9)
- A new method for therapeutic paracentesis: the automated low flow pump system. Comments in the context of the history of paracentesis. (2013) (9)
- Hepatic hemodynamics and transient elastography in alcoholic foamy degeneration: report of 2 cases. (2012) (9)
- current concepts Management of Cirrhosis and Ascites (2004) (8)
- Neuroinflammation in liver disease: sessional talks from ISHEN (2016) (8)
- 1365 ACUTE KIDNEY INJURY NETWORK (AKIN) CRITERIA FOR ACUTE RENAL FAILURE PREDICTS OUTCOME IN HOSPITALIZED CIRRHOTIC PATIENTS. A PROSPECTIVE STUDY (2011) (8)
- Hepatorenal syndrome (2000) (8)
- Proceedings: Endotoxaemia in fulminant hepatic failure. (1974) (8)
- Effect of transjugular intrahepatic portosystemic shunt (TIPS) on renal function and vasoactive systems in hepatorenal syndrome (SHR) (1998) (8)
- Management of ascites in cirrhosis (1997) (8)
- Novel Definition of Hepatorenal Syndrome: Clinical Consequences (2011) (8)
- Hepatorenal syndrome (2003) (8)
- Hepatorenal syndrome – how to assess response to treatment and nonpharmacological therapy (2004) (8)
- The role of RIPK1 mediated cell death in acute on chronic liver failure (2021) (8)
- Clinical need for antidiuretic hormone antagonists in cirrhosis (2003) (8)
- [Liver transplantation: candidate selection and results of a program for adult patients]. (1991) (8)
- Prostaglandins and renal function in cirrhosis. (1986) (7)
- Albumin protects the liver from tumor necrosis factor α‐induced immunopathology (2021) (7)
- Renal insensitivity to atrial natriuretic peptide in patients with cirrhosis and ascites. Effect of increasing systemic arterial pressure. (1992) (7)
- Treatment of ascites in patients with cirrhosis of the liver. (1987) (7)
- An Accurate Data Preparation Approach for the Prediction of Mortality in ACLF Patients using the CANONIC Dataset (2019) (7)
- 605 PLASMA COPEPTIN LEVELS ARE INCREASED IN CIRRHOSIS AND CORRELATE WITH HYPONATREMIA AND CIRCULATORY DYSFUNCTION (2013) (7)
- Lack of renal effects of fish oil administration in patients with advanced cirrhosis and impaired glomerular filtration (1997) (7)
- The selective cyclooxygenase-2 inhibitor celecoxib modulates the formation of vasoconstrictor eicosanoids and activates PPARgamma. Influence of albumin. (2005) (7)
- Biomarkers of extracellular matrix formation are associated with acute-on-chronic liver failure (2021) (7)
- Spironolactone (Sp) decreases portal pressure in patients with compensated cirrhosis (1991) (7)
- Impact of Acute-on-Chronic Liver Failure on response to treatment with terlipressin and albumin in patients with type 1 hepatorenal syndrome (2017) (7)
- 174 CLINICAL EFFICACY AND SAFETY OF TERLIPRESSIN ADMINISTRATION IN CIRRHOTIC PATIENTS WITH SEPTIC SHOCK (2009) (7)
- Untargeted lipidomics uncovers lipid signatures distinguishing severe versus moderate forms of acutely decompensated cirrhosis. (2021) (7)
- Oxidized albumin triggers a cytokine storm in leukocytes through p38 MAP kinase: role in systemic inflammation in decompensated cirrhosis. (2018) (7)
- Relationship between systemic hemodynamics, renal dysfunction, and fluid retention in cirrhosis (2013) (6)
- Albumin administration in the prevention of hepatorenal syndrome (HRS) and death in patients with advanced cirrhosis and non-SBP infections (2018) (6)
- Impact of an intestinal decontamination (ID) program on the incidence of spontaneous bacterial peritonitis (SBP) and bacteremia (SB) in hospitalized cirrhotic patients (1991) (6)
- Proceedings: Renal failure and site of abnormal renal retention of sodium in fulminant hepatic failure. (1974) (6)
- Hypernatremia following gastrointestinal bleeding in cirrhosis with ascites (1975) (6)
- Inactivation of extrahepatic vascular Akt improves systemic hemodynamics and sodium excretion in cirrhotic rats. (2010) (6)
- Ascites and hepatorenal syndrome: pathogenesis and treatment strategies. (1998) (6)
- Urinary excretion of 6-keto-prostaglandin F1α, thromboxane B2 and prostaglandin E2 in cirrhosis with ascites (1986) (6)
- Acute-on-Chronic Liver Failure, Human Serum Albumin, and Immune Modulation: The Beginning of an Exciting Adventure. (2017) (5)
- Conservative medical treatment of ovarian hyperstimulation syndrome: a single center series and cost analysis study (2013) (5)
- Reply to: "Effect of albumin on survival in septic cirrhotic patients other than spontaneous bacterial peritonitis. The question remains open". (2013) (5)
- Ascites and renal failure in primary liver cell carcinoma. (1975) (5)
- Molecular adsorbents recirculating system (MARS) and the failing liver: A negative editorial for a positive trial? (2008) (5)
- Organ allocation for patients with acute-on-chronic liver failure: Time to look beyond MELD-sodium? (2020) (5)
- Hepatorenal syndrome (2011) (5)
- The liver and the kidney: mutual clearance or mixed intoxication. (2007) (5)
- [Effect of the method of blood extraction on plasma levels of renin in the Wistar rat]. (1985) (5)
- Genetic variants of innate immunity receptors are associated with mortality in cirrhotic patients with bacterial infection (2020) (5)
- 114 Randomized, double-blind, placebo-controlled trial evaluating norfloxacin in the primary prophylaxis of spontaneous bacterial peritonitis in cirrhotics with renal impairment, hyponatremia or severe liver failure (2006) (5)
- Reversibility of hepatorenal syndrome (HRS) by the administration of terlipressin and albumin. A phase-II study (2000) (5)
- Impact of pretransplant treatment of hepatorenal syndrome (HRS) with vasopressin analogues on outcome after liver transplantation (LTX). A case-control study (2003) (5)
- Effects of atrial natriuretic peptide on urinary kallikrein excretion and renal function in rats. (1989) (5)
- Increased nitric oxide synthase expression in arterial vessels of cirrhotic rats with ascites (1996) (5)
- Recent advances in hepatorenal syndrome. (2005) (5)
- Renal and circulatory dysfunction in liver cirrhosis. Pathogenesis and treatment (2001) (4)
- Gene expression profiling of renal dysfunction in rats with experimental cirrhosis. (2006) (4)
- Hepatorenal Syndrome in Cirrhosis: Clinical Features, Diagnosis, and Management (2007) (4)
- Isosorbide 5-mononitrate (ISMN) increases plasma renin activity (PRA) and aldosterone (ALD) and impairs renal function in cirrhosis with ascites (1991) (4)
- 5-Lipoxygenase (5-LO) is Involved in Kupffer Cell Survival. Possible Role of 5-LO Products in the Pathogenesis of Liver Fibrosis (2004) (4)
- Response to the clinical course and short‐term mortality of cirrhotic patients with non‐spontaneous bacterial peritonitis infections (2017) (4)
- Practical Recommendations for the Treatment of Ascites and Its Complications (1997) (4)
- 209 CARDIOMYOPATHY IN PATIENTS WITH CIRRHOSIS. FREQUENCY, CHARACTERISTICS AND RELATIONSHIP WITH CIRCULATORY DYSFUNCTION AND PROGNOSIS (2009) (4)
- Temporal relationship between the decrease in arterial pressure and the onset of sodium retention in hypertensive rats with carbon tetrachloride induced cirrhosis (1989) (4)
- Elective Surgery but not Transjugular Intrahepatic Portosystemic Shunt Precipitates Acute‐On‐Chronic Liver Failure (2021) (4)
- Corrigendum to “Diagnosis and management of acute kidney injury in patients with cirrhosis: Revised consensus recommendations of the International Club of Ascites” [J Hepatol 2015;62:968–974] (2015) (4)
- Malignant Histocytosis Presenting as a Fulminant Hepatic Disease (1983) (4)
- Mechanism of the blunted renal response to atrial natiuretic factor (ANF) in cirrhotics with ascites, evidence against a role of impaired systemic hemodynamics (1989) (4)
- Acute-on-Chronic Liver Failure. Reply. (2020) (4)
- [Renal insufficiency in fulminating hepatitis]. (1974) (4)
- 648 HYPONATREMIA IS A MAJOR FACTOR OF THE IMPAIRED HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH CIRRHOSIS AND ASCITES (2012) (4)
- 844 COMPARISON OF AKIN CRITERIA AND CONVENTIONAL CRITERIA FOR DEFINITION OF RENAL IMPAIRMENT IN CIRRHOSIS. PRELIMINARY RESULTS OF A PROSPECTIVE STUDY (2010) (4)
- Hyperdynamic circulation and renal dysfunction in cirrhosis with ascites are not due to a generalized arteriolar vasodilation (1991) (3)
- Renal effects of amino acid administration in cirrhosis. (1993) (3)
- Effect of radiocontrast agents on renal function in patients with cirrhosis and ascites (2002) (3)
- 210 EFFECTS OF ALBUMIN ADMINISTRATION IN PATIENTS WITH CIRRHOSIS AND BACTERIAL INFECTIONS OTHER THAN SPONTANEOUS BACTERIAL PERITONITIS. A RANDOMIZED, CONTROLLED STUDY (2009) (3)
- Effect of spironolactone on the renin-aldosterone system in rats. (1988) (3)
- Acute‐on‐chronic liver failure: Is the definition ready for prime time? (2013) (3)
- Reduced Plasma Extracellular Vesicle CD5L Content in Patients With Acute-On-Chronic Liver Failure: Interplay With Specialized Pro-Resolving Lipid Mediators (2022) (3)
- 49 OSTEOPONTIN IS A NOVEL THERAPEUTIC TARGET IN PATIENTS WITH ALCOHOLIC HEPATITIS (2010) (3)
- O74 URINARY NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (NGAL) IS A STRONG PREDICTOR OF SHORT-TERM OUTCOME IN PATIENTS WITH ACUTE DECOMPENSATION OF CIRRHOSIS. RELATIONSHIP WITH ACUTE-ON-CHRONIC LIVER FAILURE (ACLF) (2014) (3)
- Intracellular and exchangeable potassium in cirrhosis (1981) (3)
- Impact of Acute-on-Chronic Liver Failure (ACLF) on response to treatment with terlipressin and albumin in patients with type 1 hepatorenal syndrome (2017) (3)
- 1018 URINARY KIDNEY INJURY MOLECULE-1 (KIM-1) IN THE ASSESSMENT OF ACUTE KIDNEY INJURY IN PATIENTS WITH CIRRHOSIS (2013) (3)
- [Spontaneous ascites compensation in liver cirrhosis]. (1974) (3)
- Refractory ascites: definition and mechanism. (1987) (3)
- [Renal insufficiency caused by diuretics in liver cirrhosis with ascites]. (1973) (3)
- 5-Lipoxygenase (5-LO) is Involved in Kupffer Cell Survival. Possible Role of 5-LO Products in the Pathogenesis of Liver Fibrosis. (2002) (3)
- P076 A multi-centre, randomized controlled study, to evaluate the safety and performance of the DIALIVE liver dialysis device in patients with acute on chronic liver failure (ACLF) versus standard of care (SOC) (ALIVER Consortium) (2021) (3)
- Corrigendum to “Terlipressin and albumin for type-1 hepatorenal syndrome associated with sepsis” [J Hepatol 2014; 60: 955–961] (2014) (3)
- Correction to 'Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF' [J Hepatol 2020 (72) 688-701]. (2020) (3)
- Hyperkalemia influences the outcome of patients with cirrhosis with acute decompensation (AD) and acute-on-chronic liver failure (ACLF). (2021) (3)
- Medical treatment of ascites (1991) (3)
- Prognostic value of C-reactive protein in patients with cirrhosis: external validation from the CANONIC cohort (2014) (3)
- P508 VALIDATION OF THE CLIF-CONSORTIUM (CLIF-C) SCORE TO PREDICT MORTALITY OF PATIENTS WITH ACUTE-ON-CHRONIC LIVER FAILURE (ACLF) IN AN EXTERNAL COHORT AND FOR SEQUENTIAL MEASUREMENTS (2014) (3)
- [Peritoneal infection in hepatic cirrhosis with ascitis]. (1971) (3)
- Electrolyte and circulatory changes in terminal liver failure (2002) (3)
- Endothelin (ET) has natriuretic effect in conscious cirrhotic rats with ascites (1990) (2)
- 1414 THE CLIF-CONSORTIUM SCORE PREDICTS MORTALITY MORE ACCURATELY THAN THE MELD AND MELD-SODIUM SCORES IN PATIENTS HOSPITALIZED WITH DECOMPENSATED CIRRHOSIS WITH AND WITHOUT ACUTE-ON-CHRONIC-LIVER FAILURE (ACLF). (2013) (2)
- P077 Pathophysiological basis of resolution of acute-on-chronic liver failure (ACLF) induced by the novel liver dialysis device, DIALIVE (ALIVER consortium) (2021) (2)
- In memory of Joan Cordoba (2014) (2)
- Other clinical studySpontaneous bacterial peritonitis in cirrhotic patients treated using paracentesis or diuretics: Results of a randomized study☆ (1995) (2)
- 950 HEPATORENAL SYNDROME ASSOCIATED WITH BACTERIAL INFECTIONS IN CIRRHOSIS. PROGNOSTIC RELEVANCE AND IMPORTANCE OF CIRCULATORY DYSFUNCTION (2011) (2)
- Hepatorenal syndrome-pathogenesis and treatment. (2002) (2)
- Reply to: "Acute-on-chronic liver failure - its definition remains unclear". (2013) (2)
- Precision in nutritional diagnoses (1993) (2)
- [Triamterene in the treatment of liver cirrhosis with ascites]. (1972) (2)
- Effect of atrial natriuretic peptide on arterial pressure and renal function in cirrhotic rats with ascites. (1988) (2)
- P1316 : Effects of long-term administration of midodrine and albumin in the prevention of complications in patients with cirrhosis on waiting list for liver transplantation. A randomized, multicenter, double-blind, placebo-controlled trial. macht study (2015) (2)
- Chapter 22 – Renal Dysfunction in Cirrhosis: Pathophysiology, Clinical Features and Therapy (2006) (2)
- Albumin versus dextran-70 IN cirrhotics with tense ascites treated with total paracentesis. Final results of a multicenter randomized comparative study (1990) (2)
- Untargeted lipidomics uncovers lipid signatures that distinguish severe from moderate forms of acutely decompensated cirrhosis ☆ (2021) (2)
- Pathophysiology and treatment of ascites in cirrhosis. (1990) (2)
- THU-036-First description of the immune checkpoint receptor landscape in decompensated cirrhosis and ACLF (2019) (2)
- Ascites, Hepatorenal Syndrome, and Spontaneous Bacterial Peritonitis (2010) (2)
- [Adrenal insufficiency in cirrhosis]. (2008) (2)
- [Physiopathological bases for the use of human albumin in liver cirrhosis]. (2012) (2)
- The treatment of ascites. (1999) (2)
- Evaluation of the CLIF-C ACLF score in critically ill cirrhotic patients in intensive care units in Europe and North America: a multicenter cohort study (2017) (2)
- 19 LIVER PROGENITOR CELL MARKERS CORRELATE WITH LIVER DAMAGE AND PREDICT SHORT-TERM MORTALITY IN PATIENTS WITH ALCOHOLIC HEPATITIS (2011) (2)
- 1019 URINARY NGAL IS USEFUL TO PREDICT CAUSE AND SEVERITY OF KIDNEY FUNCTION IMPAIRMENT AND IS A PROGNOSTIC MARKER IN PATIENTS HOSPITALIZED FOR COMPLICATIONS OF CIRRHOSIS (2013) (2)
- Erratum to “The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure” [J Hepatol 2015;62:831–840] (2015) (2)
- Diuretic-resistant ascites in cirrhosis. Mechanism and treatment. (1990) (2)
- Management of renal failure. (1971) (2)
- P937 EARLY TREATMENT WITH TERLIPRESSIN AND ALBUMIN IS EFFECTIVE FOR TYPE-1 HEPATORENAL SYNDROME ASSOCIATED WITH SEPSIS (2014) (1)
- Increased circulating levels of neuropeptide Y (NPY) in hepatorenalsyndrome (HRS). A possible role in the pathogenesis of renalvasoconstriction (2000) (1)
- Dietary n-3 polyunsaturated fatty acid supplementation: Lack of renal effect in cirrhosis with ascites (1991) (1)
- Increased systemic production of carbon monoxide in patients with cirrhosis and ascites with and without spontaneous bacterial peritonitis (SBP) (2002) (1)
- Chapter 10 – Ascites, Hyponatremia, Hepatorenal Syndrome and Spontaneous Bacterial Peritonitis (2006) (1)
- FRI-111-Albumin modulates endosomal TLR9 signaling in human peripheral leukocytes: A mechanism for its anti-inflammatory role in ACLF (2019) (1)
- 196 Cannabinoid CB1 receptors are overexpressed in resistance mesenteric arteries of cirrhotic rats with ascites (2004) (1)
- Intracellular and exchangeable potassium in cirrhosis. Evidence against the occurrence of potassium depletion in cirrhosis with ascites. (1981) (1)
- 3 Effects of celecoxib and naproxen on renal function in patients with cirrhosis and ascites: A double-blind randomized controlled trial (2004) (1)
- Contents, Vol. 42, 1986 (1984) (1)
- 952 MELD-SODIUM PREDICTS SURVIVAL AND DEVELOPMENT OF TYPE-1 HEPATORENAL SYNDROME IN PATIENTS WITH TYPE-2 HEPATORENAL SYNDROME (2011) (1)
- Hyperkalemia influences the outcome of patients with cirrhosis with acute decompensation (AD) and acute on chronic liver failure (ACLF) (2018) (1)
- [Factors responsible for renal sodium retention in hepatic cirrhosis with ascites]. (1975) (1)
- Spironolactone increases synthesis and catabolism of aldosterone in normal rats (1986) (1)
- [Training of specialists in gastroenterology. Was it time for a review?]. (2003) (1)
- Ascites and Spontaneous Bacterial Peritonitis (2017) (1)
- Renal failure in cirrhosis (2015) (1)
- O140 INTEGRATIVE MICRORNA PROFILING IDENTIFIES MIR-21 AND MIR-155 AS POTENTIAL REGULATORS IN ALCOHOLIC HEPATITIS (2014) (1)
- The Liver in Urogenital Diseases (2008) (1)
- Hepatic gene expression of activated AKT normalizes portal pressure in experimental cirrhosis (2003) (1)
- 145 EARLY MARKERS OF BACTERIAL INFECTION IN LIVER CIRRHOSIS (2010) (1)
- Immunosuppression and Increased Risk of Bacterial Infections in Cirrhosis (2021) (1)
- [Changes in "Gastroenterology and Hepatology"]. (2009) (1)
- Comparative Protection Against Liver Inflammation and Fibrosis by a Selective COX-2 Inhibitor and a Nonredox-type 5-LO Inhibitor (2007) (1)
- Treatment of ascites in patients with cirrhosis of the liver (2004) (1)
- 18 PROTEOMIC ANALYSIS IDENTIFIES P90RSK AS A NOVEL THERAPEUTIC TARGET IN PATIENTS WITH ALCOHOLIC HEPATITIS (2011) (1)
- Abstract papers presentedEndotoxin, platelet-activating factor and renal function in cirrhosis (1990) (1)
- Terlipressin and albumin for the hepatorenal syndrome. Authors' reply (2003) (1)
- Systemic inflammation, coagulation disorders and the AD-ACLF syndrome. (2021) (1)
- 234 Relationship between renal function and serum creatinine levels in patients with cirrhosis. Relevance for prognosis assessment (2006) (1)
- P1336 : Treatment of type 1 hepatorenal syndrome with terlipressin infusion adjusted according to hemodynamic response. The ameliorate study (2015) (1)
- [Water-electrolyte disorders in hepatic cirrhosis with ascites]. (1972) (1)
- 21 The selective cyclooxygenase-2 inhibitor SC-236 reduces experimental liver fibrosis by inactivating kupffer cells and acting as a peroxisome proliferator-activated receptor gamma ligand (2004) (1)
- LP21 : The macrophage activation markers soluble CD206 And CD163 predict mortality in patients with liver cirrhosis and acute-on-chronic liver failure (ACLF) (2015) (1)
- Dipyridamole induces renal failure in cirrhosis with ascites (1990) (1)
- P468 URINARY NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN PREDICTS OUTCOME OF KIDNEY FUNCTION AND MORTALITY IN PATIENTS WITH CIRRHOSIS AND BACTERIAL INFECTIONS (2014) (1)
- Urinary excretion of endogenous digitalis-like natriuretic substances in healthy subjects. Effect of sodium load. (1990) (1)
- Renal Dysfunction and Pathogenesis and Treatment of Ascites and Hepatorenal Syndrome in Cirrhosis (2011) (1)
- Albumin Lipidomics Reveals Meaningful Compositional Changes in Advanced Cirrhosis and Its Potential to Promote Inflammation Resolution (2022) (1)
- [Circulatory support with albumin in liver cirrhosis]. (2005) (1)
- Renal effects of selective cyclooxygenase inhibition in experimental liver disease. (2003) (1)
- [Physiopathology of refractory ascites and the hepatorenal syndrome]. (2002) (1)
- The endogenous cannabinoid, anandamide, produces a specific and high vasodilator effect in mesenteric vessels of cirrhotic rats (2003) (1)
- Liver Failure, Acute-on-Chronic (2020) (1)
- Correction: The role of RIPK1 mediated cell death in acute on chronic liver failure (2022) (1)
- Comprar Chronic Liver Failure. Mechanisms And Management | Pere Ginès | 9781607618652 | Humana Press (2010) (1)
- Chromatographic pattern and biological activity of atrial natriuretic factor (ANF) in cirrhosis with ascites (1989) (1)
- Reply to "Keep the sick from harm in spontaneous bacterial peritonitis: Dose of beta blockers matters". (2016) (1)
- Diagnosis and management of acute kidney injury in patients with cirrhosis : Revised consensus recommendations of the International Club of Ascites q (2015) (1)
- 94 FUNCTIONAL ANALYSIS OF HEPATIC GENE EXPRESSION PROFILING FROM PATIENTS WITH ALCOHOLIC HEPATITIS REVEALS NEW TARGETS FOR THERAPY (2009) (1)
- [Chronic liver failure: a clinical entity in need of researchers]. (2010) (1)
- Plasma Cystatin C is a predictor of renal failure, hepatorenal syndrome, ACLF and mortality in patients with acutely decompensated liver cirrhosis (2016) (0)
- Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome (2009) (0)
- 1225 FAT-1 TRANSGENIC MICE EXPRESSING AN OMEGA-3 FATTY ACID DESATURASE ARE PROTECTED FROM STEATOHEPATITIS (2012) (0)
- 677 TERLIPRESSIN AND ALBUMIN FOR TYPE-2 HEPATORENAL SYNDROME. IS IT JUSTIFIED? (2012) (0)
- To the Editor (0)
- Blunted natriuretic response to human urine extracts with Na+,K(+)-ATPase inhibiting activity in experimental cirrhosis. (1994) (0)
- Effects of the acute administration of a specific inducible nitric oxide synthase inhibitor (NOS) on splanchnic circulation in cirrhotic rats with ascites (2000) (0)
- A prognestic index (PI) for patient selection and timing of liver transplantation in cirrhosis with ascites (1991) (0)
- Ascites and Renal and Electrolyte Abnormalities in Cirrhosis (1992) (0)
- Reply to letter Ref: JHEPAT-D-16-00820 by Ustungad et al. Non selective beta-blockers in ACLF (reply) (2016) (0)
- [Specificity of the determination of urinary kallikrein activity using an amidolytic assay]. (1983) (0)
- Active renin (AR) is better than plasma renin activity (PRA) for the assessment of the renin-angiotensin system (RAS) in cirrhosis with ascites (1990) (0)
- Fibronectin plays a major role in the angiogenesis induced by ascites from cirrhotic patients (2003) (0)
- 108 Bradykinin exerts hepatoprotective and antifibrogenic effects in experimental liver fibrosis (2006) (0)
- ORIGINAL ARTICLES—LIVER, PANCREAS, AND BILIARY TRACT Acute Kidney Injury Is an Early Predictor of Mortality for Patients With Alcoholic Hepatitis (2012) (0)
- Liver Transplantation Interdisciplinary Conference (1) (2009) (0)
- Novel experimental animal models for acute decompensation and acute-on-chronic liver failure (2020) (0)
- Reply (2017) (0)
- Vasoactive factors potentially involved in the regulation of renal perfusion in cirrhosis and in the pathogenesis of hepatorenal syndrome (0)
- 134 DECREASED HEPATIC MACROPHAGE INFILTRATION, INSULIN RESISTANCE AND TNFa-INDUCED HEPATOCYTE DAMAGE IN APOE/5-LIPOXYGENASE DOUBLE KNOCKOUT MICE (2009) (0)
- Oxidized albumin present in patients with decompensated cirrhosis triggers the inflammatory response in peripheral leukocytes through the p38 MAP kinase pathway (2018) (0)
- Spontaneous bacterial peritonitis (SBP) treated with cefotaxime: Predictive factors of infection resolution and patient survival (1991) (0)
- Neck "ascites" after peritoneovenous shunt. (1990) (0)
- THU-050-Genetic variants of innate immunity receptors are associated with mortality but not with bacterial infections in liver cirrhosis (2019) (0)
- 58 Hepatocarcinoma cells stimulate proliferation and migration and inhibit fibrogenic actions in human hepatic stellate cells: Regulation by hepatitis C virus proteins (2006) (0)
- EASL International Recognition Award Recipient 2019: Prof. Flair José Carrilho. (2019) (0)
- The Effect of Liver Disease on the Urogenital Tract (2008) (0)
- [Liver cirrhosis: pathogenesis of ascites and disturbance of renal function]. (1992) (0)
- Identification of Cell Apoptosis by Terminal Deoxynucleotidyl Transferase – Mediated Deoxyuridine Triphosphate Nick-End Labeling (0)
- Lack of effect of misoprostol, an orally active prostaglandin E1 analogue, and of I.V. prostaglandin E2 (PGE2) on renal function in patients with cirrhosis and ascites (1990) (0)
- 18 Norepinephrine induces inflammatory actions and calcium mobilization in human hepatic stellate cells through alpha receptors (2004) (0)
- Combination of CCL4-induced decompensated cirrhosis with acute polymicrobial peritonitis as an optimized experimental model mimicking extrahepatic organ failures defined in ACLF (2022) (0)
- 219 Relative adrenal insufficiency in cirrhotic patients with septic shock. Effects of treatment on survival (2006) (0)
- [Treatment of cirrhotic ascites. Paracentesis again?]. (1987) (0)
- Proteomic analysis to identify the pathophysiological role of placental growth factor (Plgf) in hepatic stellate cell function and cirrhosis (2008) (0)
- Coordinate functional regulation between microsomal prostaglandin E synthase-1 and PPARγ in the conversion of white-to-brown adipocytes* (2013) (0)
- P343 IDENTIFICATION OF A NOVEL HEXOKINASE IN PATIENTS WITH ALCOHOLIC HEPATITIS (2014) (0)
- Pro-Resolving Lipid Mediators Modulate the NLRP3 Inflammasome in Chronic Liver Disease (2016) (0)
- Reply (2003) (0)
- 845 LIVER, RENAL, AND CIRCULATORY DYSFUNCTION IN HEPATORENAL SYNDROME WITH AND WITHOUT BACTERIAL INFECTION. A PROSPECTIVE STUDY (2010) (0)
- Albumin function in acute-on-chronic liver failure (ACLF): Effect of plasma exchange with albumin 5% (PE-A5%) (2018) (0)
- [Refractory ascites in liver cirrhosis. Pathogenesis and treatment]. (1989) (0)
- Patients with acutely decompensated cirrhosis present a distorted blood lipid landscape that affects the ability of albumin to promote inlammation resolution (2022) (0)
- Hepatorenal syndrome. (1998) (0)
- Use of Non-selective Beta-blockers in Decompensated Cirrhosis: Controversy Continues (2016) (0)
- Neuroinflammation in liver disease: sessional talks from ISHEN (2016) (0)
- Renal Function in Liver Disease (2009) (0)
- [Hyperpotassemia as cause of death in hepatic cirrhosis]. (1974) (0)
- Polymorphismus in the Interleukin (IL)-1 Gene Cluster Influence the Inflammatory Burden in Patients with Decompensated Cirrhosis and Acute-On-Chronic Liver Failure (2016) (0)
- P0135 : Impact of vasopressin AVP1A receptor gene polymorphisms on mortality and renal failure in patients with acute decompensation of chronic liver disease (2015) (0)
- Epidemiology : Patients with Cirrhosis Requiring Intensive Care (2011) (0)
- Importance of the Cause of Renal Failure in Patients ith Cirrhosis (0)
- Reply (2016) (0)
- Antibiotics and renal tubular damage in cirrhosis (1983) (0)
- Wide variations in liver transplantation (LT) policies across Europe for patients with acute-on-chronic liver failure (ACLF) despite excellent post-LT survival: Results of a CLIF/ELITA collaborative study (2020) (0)
- 67 LIVER CELL-SPECIFIC PPARg CONDITIONAL-NULL MICE ESTABLISH ANTI-INFLAMMATORY AND ANTI-FIBROGENIC PROPERTIES FOR THIS NUCLEAR RECEPTOR IN KUPFFER CELLS (2012) (0)
- 17 RENAL FAILURE IN CIRRHOSIS: PROGNOSTIC VALUE OF THE AETIOLOGY OF RENAL FAILURE. A PROSPECTIVE STUDY OF 562 PATIENTS (2010) (0)
- Hepatocytes contribute to the increased hepatic production of cysteinyl leukotrienes in rats with cirrhosis (1998) (0)
- The kynurenine pathway in cirrhosis. Relationship with the development of acute decompensation and acute-on-chronic liver failure, clinical course and mortality (2018) (0)
- 272 PREDICTIVE FACTORS OF SURVIVAL IN PATIENTS WITH CIRRHOSIS AND HYPONATREMIA. RELEVANCE OF MELD SCORE AND TYPE OF HYPONATREMIA (2008) (0)
- Different inflammasome activation predisposes for acute-on-chronic liver failure depending on hepatic compensation in human and experimental liver cirrhosis (2020) (0)
- Effects Q1 of Albumin Q2 Treatment Q3 on Systemic and Portal Hemodynamics and Systemic In fl ammation in Patients With Decompensated Cirrhosis (2019) (0)
- Modulation of suPAR by chronic liver inflammation (2013) (0)
- Regulation of IL-22 in a rat model for acute-on-chronic liver failure (ACLF) (2020) (0)
- POSTERSPoster Session – Saturday, 12 April 20142C. CIRRHOSIS AND ITS COMPLICATIONS: BLEEDING, HEPATORINAL SYNDROME AND ASCITISP935 TRANSIENT INCREASE IN URINE PROTEIN EXCRETION DURING TREATMENT WITH TERLIPRESSIN AND ALBUMIN FOR TYPE 1 HEPATORENAL SYNDROME (2014) (0)
- Reply to "Futility of care in patients with acute-on-chronic liver failure". (2017) (0)
- Short article: Impact of genetic variation in the vasopressin 1a receptor on the development of organ failure in patients admitted for acute decompensation of liver cirrhosis (2017) (0)
- Severe alcoholic hepatitis as precipitant for organ failure and ACLF. (2022) (0)
- [117] APELIN, A NOVEL NEUROENDOCRINE PEPTIDE, PLAYS AN IMPORTANT ROLE IN THE PATHOGENESIS OF THE CARDIOVASCULAR DYSFUNCTION IN CIRRHOSIS (2007) (0)
- [Clinical practice guidelines in gastroenterology and hepatology. A resource underused by the Spanish Association for the Study of the Liver and the Spanish Association of Gastroenterology]. (2012) (0)
- 513 CCL20 AS POTENTIAL MEDIATOR OF INFLAMMATION AND FIBROSIS IN PATIENTS WITH ALCOHOLIC HEPATITIS: EVIDENCES OF A TRANSLATIONAL STUDY (2013) (0)
- Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with ACLF across Western Europe (2019) (0)
- Reply to: "Non-selective beta-blockers for the patients with acute on chronic liver failure". (2016) (0)
- The TLR10 polymorphism rs4129009 is associated to poor 28-day survival in patients with cirrhosis and acute on chronic liver failure precipitated by bacterial infection (2016) (0)
- 30 – Hepatorenal Syndrome and Other Liver-Related Kidney Diseases (2014) (0)
- Relationship between circulatory function and severity of renal failure in patients with cirrhosis and hepatorenal syndrome (2003) (0)
- Sympathetic nervous activation, mitochondrial dysfunction and outcome in acutely decompensated cirrhosis: the metabolomic prognostic models (CLIF-C MET) (2023) (0)
- Docosahexaenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators: protectin D1 and 17Sâ•’hydroxyâ•’DHA (2006) (0)
- TLR-10 Single Nucleotide Polymorphism is Associated to Poor Short Term Survival in Cirrhotic Patients with Acute on Chronic Liver Failure Precipitated by Bacterial Infections (2016) (0)
- Table 1 Clinical characteristics of patients at diagnosis of spontaneous bacterial peritonitis episodes who did receive (A) and who did not receive (B) albumin (2015) (0)
- Vascular remodeling in cirrhosis: structural features and hemodynamic consequences (2002) (0)
- [Technics for the study of the renal excretion of free water in normal rats and those with experimental liver cirrhosis]. (1986) (0)
- [Determination of arginine-vasopressin in small volumes of rat plasma]. (1986) (0)
- 677 Hepatic gene expression analysis in acute alcoholic hepatitis identifies nadph oxidase and GRO-α as potential therapeutical targets (2006) (0)
- [Physiopathology and treatment of ascites in the cirrhotic patient]. (1987) (0)
- Conservative medical treatment of ovarian hyperstimulation syndrome (OHSS): results of a large series in a single centre and cost analysis study (2012) (0)
- Are there any characteristic changes in the plasma concentration of atrial natriuretic factor in liver cirrhosis? (1989) (0)
- Advances in the pathogenesis and treatment of type 1 and type 2 heapatorenal Syndrome (2007) (0)
- 711 5-LIPOXYGENASE ACTIVATING PROTEIN, FLAP, SIGNALS ADIPOSE TISSUE INFLAMMATION AND STEATOGENIC POTENTIAL IN OBESITY (2009) (0)
- Pro-Resolving Lipid Mediators Modulate Hypoxia-Induced and Lipotoxic ER Stress in Primary Hepatocytes (2016) (0)
- Ascites reduction and anti-inflammatory effects after albumin infusion for the management of cirrhosis: evidence from an animal model (2022) (0)
- Somatostatin (SMT) reduces urinary prostaglandin (PG) excretion and impairs renal function in cirrhosis with ascites (1991) (0)
- Reply: (2004) (0)
- P601 CCR6 DEFICIENCY ENHANCES LIVER INFLAMMATION AND FIBROSIS BY MODULATING HEPATIC MACROPHAGES M1/M2 BALANCE AND INFLAMMATORY CELLS RECRUITMENT (2014) (0)
- acute liver damage . compared with other causes of in paracetamol overdose Frequency of renal impairment (2004) (0)
- Essential role for albumin in preserving liver cells from TNFα‐induced mitochondrial injury (2023) (0)
- P112 LIVER DAMAGE DETERMINES THE GENE EXPRESSION PROFILE OF LIVER PROGENITOR CELLS AND THEIR CONTRIBUTION TO HEPATIC REGENERATION (2014) (0)
- [Treatment of the syndrome of inappropriate antidiuretic hormone secretion with demethylchlortetracycline (author's transl)]. (1979) (0)
- Cirrhosis and ascites (2020) (0)
- Urinary beta 2-microglobulin and serum bilirubin concentrations in hepatorenal syndrome and acute tubular necrosis. (1986) (0)
- Renal insensitivity to natriuretic hormone (NH) in conscious rats with cirrhosis and ascites (1991) (0)
- Intracellular calcium concentration ([Ca12+]) in vascular smooth muscle cells (VSMC) of cirrhotic rats. Effect of angiotensin II (AII) (1991) (0)
- P-3 PLASMA EXCHANGE WITH ALBUMIN INCREASES EFFECTIVE ALBUMIN LEVELS IN PATIENTS WITH ACUTE-ON-CHRONIC LIVER FAILURE (2023) (0)
- Genetic determinants influencing on overt hepatic encephalopathy and acute-on-chronic liver failure (2017) (0)
- [Acute pseudotumoral alcoholic hepatitis]. (1973) (0)
- 176 Temporal relationship between systemic and splancnic vasodilatation, NOS activity and ascites formation in cirrhotic rats (2004) (0)
- Letter: Ascites and oedema in liver disease. (1973) (0)
- [Renal perfusion and the renin-angiotensin system in hepatic cirrhosis]. (1978) (0)
- 189 CIRRHOTIC CARDIOMYOPATHY: ABNORMAL VENTRICULAR FILLING OR ACTUAL MYOCARDIAL DYSFUNCTION? (2011) (0)
- Predictive factors and outcome of hepatorenal syndrome in cirrhosis. Relevance of serum sodium concentration (2003) (0)
- Correction: The role of RIPK1 mediated cell death in acute on chronic liver failure (2022) (0)
- 1126 IDENTIFICATION OF p90RSK AS A NOVEL THERAPEUTIC TARGET FOR LIVER FIBROSIS (2013) (0)
- 37 THE BILIARY COMPARTMENT IS THE ORIGIN OF LIVER PROGENITOR CELLS AND CONTRIBUTES TO NEWLY GENERATED HEPATOCYTES IN HEPATIC REGENERATION (2013) (0)
- PS-104-Prognosis assessment of acute-on-chronic liver failure in patients with hepatitis B virus-related cirrhosis requires specific criteria (2019) (0)
- 1292 RESOLVIN D1 PRIMES INFLAMMATION-RESOLUTION PROGRAMMES DURING MODERATE CALORIE RESTRICTION IN OBESITY-INDUCED NASH (2013) (0)
- Novel APOB mutation in familial hypobetalipoproteinemia. (2021) (0)
- PS-145-Albumin protects the liver from tumour necrosis factor alpha-induced cell death (2019) (0)
- Reply: (2005) (0)
- 100 CIGARETTE SMOKING EXACERBATES NON-ALCOHOLIC STEATOHEPATITIS IN OBESE RATS (2008) (0)
- The Editorial Office thanks the following colleagues for reviewing papers for the period of 1 November 2000 to 31 October 2001 (2002) (0)
- Proceedings: Intrarenal distribution of blood flow in cirrhosis as measured by transit renography: relation to sodium excretion and plasma renin activity. (1975) (0)
- [Determination of the concentration of gentamycin in the renal tissue of rats by radioimmunoassay]. (1984) (0)
- Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with ACLF across Europe (2018) (0)
- Soluble immune checkpoints are involved in the immunopathogenesis of ACLF (2020) (0)
- Brexit from current guideline recommendations? (2016) (0)
- A More Intensive Regimen of Albumin Dyalisis Improves Survival in Patients with Acute on Chronic Liver Failure. Results from an Individual-Patient Data Meta-Analysis (2016) (0)
- Erratum to Practical recommendations for the treatment of ascites and its complications (2012) (0)
- [Portal hypertension, ascites and functional renal insufficiency in a patient with agnogenic myeloid metaplasia]. (1982) (0)
- Evidence for a role of endothelium derived relaxing factor (EDRF) in the arterial hypotension and secondary sodium retention in cirrhosis (1991) (0)
- Mineralocorticoid escape in compensated cirrhotics with portal hypertension. Relationship with natriuretic and antinatriuretic systems (1990) (0)
- P344 TRANSLATIONAL STUDY IDENTIFIES NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (NGAL) AS A POTENTIAL MEDIATOR OF LIVER INJURY AND FIBROGENESIS IN ALCOHOLIC HEPATITIS (2014) (0)
- Reply to: "Metabolomics to discriminate between acute decompensation and acute-on-chronic liver failure in cirrhosis". (2020) (0)
- The Mortality of Acute-on-Chronic Liver Failure by APASL vs. EASL-CLIF definition: A Multicenter, Retro- spective Cohort Study in Korea (KACLiF Study) (2014) (0)
- [The Spanish System of Accreditation of Professional Competencies in Hepatology. A proposal of the Spanish Association for the Study of the Liver]. (2008) (0)
- P0185 : Acute-on-Chronic Liver Failure not associated with bacterial infections. Characteristics, prognosis and importance of systemic inflammatory response (2015) (0)
- Long-term 20% albumin administration normalizes the plasma albumin binding capacity in patients with decompensated cirrhosis (2020) (0)
- The Legacy of Juan Rodés (1938–2017), a European Leader in Hepatology and Clinical Research (2017) (0)
- [199] VASCULAR ENDOTHELIAL GROWTH FACTOR TYPE A (VEGF-A) AND ANGIOPOIETIN-2 (ANG-2) ARE RELEVANT IN THE PATHOGENESIS OF THE INCREASED VASCULAR PERMEABILITY IN CIRRHOSIS (2007) (0)
- 485 IDENTIFICATION OF CCL20 AS A NOVEL MEDIATOR OF INFLAMMATION AND FIBROSIS IN ALCOHOLIC HEPATITIS (2011) (0)
- 911 THE ABIC SCORE: A NEW TOOL FOR PROGNOSTIC STRATIFICATION OF PATIENTS WITH ALCOHOLIC HEPATITIS (2008) (0)
- 145 THERAPEUTIC TARGETS IN LIVER TRANSPLANTATION: ANGIOTENSIN II IN NON-STEATOTIC GRAFTS AND ANGIOTENSIN-(1–7) IN STEATOTIC GRAFTS (2009) (0)
- [Accreditation of processes in hepatology]. (2008) (0)
- Impact of genetic variation in the vasopressin 1a receptor on the development of organ failure in patients admitted for acute decompensation of liver cirrhosis. (2017) (0)
- Reply to: “Systemic inflammation and disorders of hemostasis in the AD-ACLF syndrome” (2021) (0)
- Reply to “Decisions on futility in patients with cirrhosis and organ failure” (2016) (0)
- Identification of new biomarkers of leukocyte dysfunction by lipidomics in patients with acute-on-chronic liver failure (2017) (0)
- [Is a low-sodium diet necessary in patients with ascites?]. (1985) (0)
- M2-Like Macrophage Polarization toward an Adipose Tissue Inflammation by Eliciting Docosahexaenoic Acid Promote Resolution of Resolvin D1 and Its Precursor (2011) (0)
- [Physiopathology of ascites in cirrhosis. A multidisciplinary problem]. (1987) (0)
- More on the comparison of paracentesis versus diuretics in the treatment of patients with tense ascites (1988) (0)
- This information is current as Dysfunction in Experimental Obesity Adipose Tissue Inflammation and Lipid 5-Lipoxygenase Activating Protein Signals (2010) (0)
- Reduction of advanced liver fi brosis by targeted delivery of the angiotensin II receptor antagonist losartan to hepatic stellate cells (2006) (0)
- Combinations of inflammatory markers, soluble (s)CD163, mannose receptor (sMR) and neutrophil gelatinase associated lipocalin (NGAL), predicts mortality in patients with acute-on-chronic liver failure (2018) (0)
- [Endotoxin and hepatic cirrhosis]. (1979) (0)
- 34 Anandamide is a powerful and selective vasodilator in the mesenteric resistance arteries of cirrhotic rats (2003) (0)
- Human hepatic stellate cells express membrane proteins involved in antigen presentation and T-cell activation and internalize extracellular material (2003) (0)
- Invited Commentary (2002) (0)
- [231] CEREBRAL MAGNETIC RESONANCE IMAGING REVEALS FINDINGS COMPATIBLE WITH GRAY AND WHITE MATTER LOSS IN PATIENTS WITH CIRRHOSIS (2007) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Vicente Arroyo?
Vicente Arroyo is affiliated with the following schools:
